OTCMKTS:IPIX Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis → [Urgent] Your ESG score is here (From Weiss Ratings) (Ad) Free IPIX Stock Alerts $0.0012 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.0001▼$0.001250-Day Range N/A52-Week Range$0.00▼$0.02Volume3,000 shsAverage Volume544,107 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Innovation Pharmaceuticals alerts: Email Address Ad Weiss Ratings[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.Click here to watch it before it’s too late. About Innovation Pharmaceuticals Stock (OTCMKTS:IPIX)Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.Read More IPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IPIX Stock News HeadlinesApril 10, 2024 | forbes.comInnovationRx: $90 Million To Make Drugs In SpaceMarch 25, 2024 | msn.comIndia's healthcare innovation market poised to double by 2028June 18, 2024 | Weiss Ratings (Ad)[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.February 29, 2024 | msn.comPharma company Jubilant Biosys plans to expand India footprint, to foray into new therapeutic areas, says CEO Giuliano PerfettiJanuary 4, 2024 | msn.comHealthcare & Pharma Outlook 2024: Companies to focus on quality, sustainability, and accessibility; Surge in R&D expectedDecember 25, 2023 | msn.com3 Stocks at the Forefront of Medical InnovationNovember 14, 2023 | morningstar.comInnovation Pharmaceuticals Inc IPIXNovember 14, 2023 | morningstar.comInnovation Pharmaceuticals Inc IPIXJune 18, 2024 | Weiss Ratings (Ad)[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.November 5, 2023 | msn.comEU proposal may accelerate pharma innovation decline, industry group saysOctober 27, 2023 | msn.comHow CPI's latest project will help to digitally transform the pharma industrySeptember 26, 2023 | msn.comPharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health MinisterAugust 28, 2023 | finance.yahoo.comInnovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024August 2, 2023 | uk.investing.comCSPC Innovation Pharmaceutical Co Ltd Class A (300765)June 21, 2023 | finance.yahoo.comInnovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal DiseasesJune 5, 2023 | finance.yahoo.comInnovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration TestingMay 31, 2023 | finance.yahoo.comIPIX - Innovation Pharmaceuticals Inc.May 21, 2023 | msn.comFocus on pharma: Knowledge, drive and FDI has made Ireland a global hub of innovationMay 16, 2023 | msn.comPrestige Wealth, Innovation Beverage, Scripps Safe slash IPO sizesApril 17, 2023 | finance.yahoo.comInnovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature CommunicationsApril 4, 2023 | marketwatch.comAI in Pharmaceutical Market 2023 Size and Forecast to 2031April 1, 2023 | wsj.comCSPC Innovation Pharmaceutical Co. Ltd. AMarch 20, 2023 | bizjournals.comWVU Innovation adds 3 new tenantsMarch 15, 2023 | finance.yahoo.comInnovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic ResearchersFebruary 23, 2023 | finance.yahoo.comInnovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA SubmissionFebruary 17, 2023 | marketwatch.comHealth Supplement Market 2023 : Business Scenario, Corporate Profiles, Size and Dynamic Innovation by 2028February 17, 2023 | marketwatch.comActive Pharmaceutical Ingredients Market Report Historical, Current, and Projected Size, in terms of value 2028See More Headlines Receive IPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:IPIX CUSIPN/A CIK1355250 Webwww.cellceutix.com Phone(978) 921-4125FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Leo Ehrlich CPA (Age 66)Chairman, CEO, CFO, Principal Accounting Officer & Secretary Comp: $515.85kMs. Jane Harness M.S. (Age 56)MP, Senior Vice President of Clinical Sciences & Portfolio Management Comp: $275kMr. Jim BoeheimBusiness AdvisorKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors IPIX Stock Analysis - Frequently Asked Questions How have IPIX shares performed in 2024? Innovation Pharmaceuticals' stock was trading at $0.0049 at the beginning of the year. Since then, IPIX stock has decreased by 75.5% and is now trading at $0.0012. View the best growth stocks for 2024 here. Are investors shorting Innovation Pharmaceuticals? Innovation Pharmaceuticals saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 6,600 shares, a drop of 60.2% from the May 15th total of 16,600 shares. Based on an average daily volume of 86,300 shares, the days-to-cover ratio is currently 0.1 days. View Innovation Pharmaceuticals' Short Interest. What other stocks do shareholders of Innovation Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Pharmaceuticals investors own include Vaxart (VXRT), Broadcom (AVGO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), CytoDyn (CYDY), ServiceNow (NOW), Sorrento Therapeutics (SRNE), United Airlines (UAL), Heat Biologics (HTBX) and Micron Technology (MU). How do I buy shares of Innovation Pharmaceuticals? Shares of IPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IPIX) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovation Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovation Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
